文献速递免疫规划传染病防控与疫情报告卫生政策与健康促进

澳大利亚1991-2016年复发性侵袭性肺炎球菌疾病风险评估

Estimating the risk of recurrent invasive pneumococcal disease in Australia, 1991-2016.
PubMed 文献 · Vaccine · 2021-09-02

该研究基于澳大利亚1991-2016年常规公共卫生监测数据,分析28,218名个体中28,809次侵袭性肺炎球菌疾病(IPD)发作,发现512人(1.8%)发生591次复发。2001-2016年复发性IPD发病率为216.2/10万人年,是同期原发性IPD人群发病率(8.0/10万人年)的27倍。2011-2016年超过四分之一的复发个体在首次发作时未识别出IPD风险因素。结论认为既往IPD发作者应被列为高风险群体并接种肺炎球菌疫苗。

要点

  • 复发性IPD发病率216.2/10万人年,为原发IPD人群发病率的27倍。
  • 既往IPD发作者应被识别为高风险群体并接受肺炎球菌疫苗接种。

核心结论

  • 初次IPD发作后复发风险显著增加,且至少四分之一复发者首次发作时无识别风险因素。
  • 既往IPD发作者应被列为高风险群体并接种肺炎球菌疫苗。

研究设计与样本

  • 基于澳大利亚1991-2016年常规公共卫生监测数据的回顾性队列分析,纳入至少一次IPD发作的澳大利亚居民。
  • 复发发病率从2001年起采用时间-事件分析计算,个体在初次发作后存活超过14天才贡献风险人时。

主要发现

  • 1991-2016年共28,218名个体发生28,809次IPD发作,512人(1.8%)经历591次复发。
  • 2001-2016年复发性IPD发病率为216.2/10万人年,是同期原发性IPD人群发病率(8.0/10万人年)的27倍。
  • 2011-2016年超过四分之一的复发个体在首次发作时未识别出IPD风险因素。

临床怎么用

  • 临床应将既往IPD发作史视为高风险标志,主动评估并推荐肺炎球菌疫苗接种。
  • 即使首次发作时无传统IPD风险因素,仍需警惕复发风险并纳入预防管理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Individuals who experience an initial episode of invasive pneumococcal disease (IPD) are at increased risk of recurrent episodes. However, the magnitude of risk has not been well-quantified in the pneumococcal conjugate vaccine era. Individuals with a previous episode of IPD are not commonly identified as a high-risk group in vaccination guidelines. METHODS: Australian residents with at least one case of IPD between 1991 and 2016 were identified using routine public health surveillance data which included identified IPD risk factors. Incidence of recurrent IPD was calculated from 2001 onwards (after IPD became nationally notifiable) using time-to-event analyses with individuals contributing person-time at risk of recurrence if they survived greater than 14 days after initial episode onset. RESULTS: From 1991 to 2016 there were 28,809 IPD episodes in 28,218 individuals. A total of 512 (1.8%) persons experienced 591 recurrent episodes. From 2001 to 2016 the incidence of recurrent IPD was 216.2 per 100,000 person-years, 27 times greater than the population rate of primary IPD during this period (8.0 per 100,000 population per year). Between 2011 and 2016, more than one-quarter of individuals experiencing recurrence had no IPD risk factors identified at first episode. CONCLUSIONS: There is substantially increased risk of recurrent IPD after an initial episode. At least one-quarter of those with recurrent episodes have no identified risk factors at the initial episode. Given the potential preventability of future episodes, those with a previous IPD episode should be identified as a high-risk group and receive pneumococcal vaccination.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Malo JA, Ware RS, Lambert SB, et al. Estimating the risk of recurrent invasive pneumococcal disease in Australia, 1991-2016. Vaccine. 2021. PMID: 34483025. doi:10.1016/j.vaccine.2021.08.095

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。